213 related articles for article (PubMed ID: 29460735)
1. Acquired Resistance to Antituberculosis Drugs in England, Wales, and Northern Ireland, 2000-2015.
Loutet MG; Davidson JA; Brown T; Dedicoat M; Thomas HL; Lalor MK
Emerg Infect Dis; 2018 Mar; 24(3):524-533. PubMed ID: 29460735
[TBL] [Abstract][Full Text] [Related]
2. Previous treatment in predicting drug-resistant tuberculosis in an area bordering East London, UK.
Melzer M; Gupta N; Petersen I; Cook S; Hall B
Int J Infect Dis; 2010 Aug; 14(8):e717-22. PubMed ID: 20542460
[TBL] [Abstract][Full Text] [Related]
3. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
[TBL] [Abstract][Full Text] [Related]
4. Later emergence of acquired drug resistance and its effect on treatment outcome in patients treated with Standard Short-Course Chemotherapy for tuberculosis.
Gao J; Ma Y; Du J; Zhu G; Tan S; Fu Y; Ma L; Zhang L; Liu F; Hu D; Zhang Y; Li X; Li L; Li Q
BMC Pulm Med; 2016 Feb; 16():26. PubMed ID: 26846562
[TBL] [Abstract][Full Text] [Related]
5. Acquired Drug Resistance in Mycobacterium tuberculosis and Poor Outcomes among Patients with Multidrug-Resistant Tuberculosis.
Kempker RR; Kipiani M; Mirtskhulava V; Tukvadze N; Magee MJ; Blumberg HM
Emerg Infect Dis; 2015 Jun; 21(6):992-1001. PubMed ID: 25993036
[TBL] [Abstract][Full Text] [Related]
6. Tuberculosis in Greece: bacteriologically confirmed cases and anti-tuberculosis drug resistance, 1995-2009.
Papaventsis D; Nikolaou S; Karabela S; Ioannidis P; Konstantinidou E; Marinou I; Sainti A; Kanavaki S
Euro Surveill; 2010 Jul; 15(28):. PubMed ID: 20650053
[TBL] [Abstract][Full Text] [Related]
7. Multidrug- and isoniazid-resistant tuberculosis in three high HIV burden African regions.
Sanchez-Padilla E; Ardizzoni E; Sauvageot D; Ahoua L; Martin A; Varaine F; Adatu-Engwau F; Akeche G; Salaniponi F; Bonnet M
Int J Tuberc Lung Dis; 2013 Aug; 17(8):1036-42. PubMed ID: 23827027
[TBL] [Abstract][Full Text] [Related]
8. Development of acquired drug resistance in recurrent tuberculosis patients with various previous treatment outcomes.
Yoshiyama T; Yanai H; Rhiengtong D; Palittapongarnpim P; Nampaisan O; Supawitkul S; Uthaivorawit W; Mori T
Int J Tuberc Lung Dis; 2004 Jan; 8(1):31-8. PubMed ID: 14974743
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of Mycobacterium bovis Disease in Humans in England, Wales, and Northern Ireland, 2002-2014.
Davidson JA; Loutet MG; O'Connor C; Kearns C; Smith RM; Lalor MK; Thomas HL; Abubakar I; Zenner D
Emerg Infect Dis; 2017 Mar; 23(3):377-386. PubMed ID: 28220748
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for acquisition of drug resistance during multidrug-resistant tuberculosis treatment, Arkhangelsk Oblast, Russia, 2005-2010.
Smith SE; Ershova J; Vlasova N; Nikishova E; Tarasova I; Eliseev P; Maryandyshev AO; Shemyakin IG; Kurbatova E; Cegielski JP
Emerg Infect Dis; 2015 Jun; 21(6):1002-11. PubMed ID: 25988954
[TBL] [Abstract][Full Text] [Related]
11. Drug-resistance of Mycobacterium tuberculosis in Patras, Greece.
Trakada G; Tsiamita M; Spiropoulos K
Monaldi Arch Chest Dis; 2004; 61(1):65-70. PubMed ID: 15366340
[TBL] [Abstract][Full Text] [Related]
12. Drug susceptibility profiles of pulmonary Mycobacterium tuberculosis isolates from patients in informal urban settlements in Nairobi, Kenya.
Kerubo G; Amukoye E; Niemann S; Kariuki S
BMC Infect Dis; 2016 Oct; 16(1):583. PubMed ID: 27756241
[TBL] [Abstract][Full Text] [Related]
13. Drug resistance in initial isolates of Mycobacterium tuberculosis in England and Wales, 1982-1991.
Warburton AR; Jenkins PA; Waight PA; Watson JM
Commun Dis Rep CDR Rev; 1993 Dec; 3(13):R175-9. PubMed ID: 7507770
[TBL] [Abstract][Full Text] [Related]
14. Nationwide survey of anti-tuberculosis drug resistance in Mongolia.
Buyankhishig B; Naranbat N; Mitarai S; Rieder HL
Int J Tuberc Lung Dis; 2011 Sep; 15(9):1201-5, i. PubMed ID: 21943846
[TBL] [Abstract][Full Text] [Related]
15. [Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997].
Augustynowicz-Kopeć E; Zwolska Z; Jaworski A; Kostrzewa E; Klatt M; Swiderska A; Drozd I
Pneumonol Alergol Pol; 2002; 70(3-4):193-202. PubMed ID: 12271966
[TBL] [Abstract][Full Text] [Related]
16. [Resistance of Mycobacterium tuberculosis to antituberculotic drugs in Czech Republic in 2003].
Homolka J; Krejbich F; Havelková M
Cas Lek Cesk; 2004; 143(12):836-9. PubMed ID: 15730215
[TBL] [Abstract][Full Text] [Related]
17. Molecular epidemiology study of Mycobacterium tuberculosis and its susceptibility to anti-tuberculosis drugs in Indonesia.
Lisdawati V; Puspandari N; Rif'ati L; Soekarno T; M M; K S; Ratnasari L; Izzatun N; Parwati I
BMC Infect Dis; 2015 Aug; 15():366. PubMed ID: 26297576
[TBL] [Abstract][Full Text] [Related]
18. The Mycobacterium tuberculosis Uganda II family and resistance to first-line anti-tuberculosis drugs in Uganda.
Ezati N; Lukoye D; Wampande EM; Musisi K; Kasule GW; Cobelens FG; Kateete DP; Joloba ML
BMC Infect Dis; 2014 Dec; 14():703. PubMed ID: 25523472
[TBL] [Abstract][Full Text] [Related]
19. Response to Isoniazid-Resistant Tuberculosis in Homeless Shelters, Georgia, USA, 2015-2017.
Holland DP; Alexander S; Onwubiko U; Goswami ND; Yamin A; Mohamed O; Sales RM; Grant G; Talboy P; Ray S; Toomey KE
Emerg Infect Dis; 2019 Mar; 25(3):593-595. PubMed ID: 30789335
[TBL] [Abstract][Full Text] [Related]
20. Nationwide survey of drug-resistant tuberculosis in the United States.
Bloch AB; Cauthen GM; Onorato IM; Dansbury KG; Kelly GD; Driver CR; Snider DE
JAMA; 1994 Mar; 271(9):665-71. PubMed ID: 8080502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
